20 percent more patients were treated with proton therapy in 2019
An individual eye shield is made for each patient to protect the surrounding tissue from the proton beam. © HZB
Number of patients who received the proton therapy offered jointly by Charité and HZB. © HZB/J. Politt
For more than 20 years, Charité - Universitätsmedizin Berlin and the Helmholtz-Zentrum Berlin (HZB) have jointly offered the irradiation of eye tumors with protons. In 2019, more patients were treated in Berlin-Wannsee than ever before. 276 patients - 20 percent more than in the previous year - underwent proton therapy. The treatment is specialized in choroidal melanomas of the eye. The proton accelerator at HZB is the only treatment facility for this disease in Germany.
500 to 600 people in Germany are affected by a malignant choroidal melanoma every year. In 97 percent of cases, the tumour can be completely destroyed by irradiation with protons. In most cases, not only the eye but also the vision can be maintained to a satisfactory degree. "The energy of the proton beam can be adjusted in such a way that practically only the tumor receives the radiation. Since the protons have a straight trajectory, the lateral scattering is much less than with X-rays," explains Dr. Jens Heufelder, the senior medical physicist at Charité - Universitätsmedizin Berlin. The protons effectively destroy the tumor, while the surrounding healthy tissue is largely spared.
To cope with the increase in patients in 2019, treatment operations at the proton accelerator have been extended to 12 hours. Approximately 45 percent of the patients came from the Berlin-Brandenburg region, the other patients came from other German states and other European countries (approximately 8 percent). The youngest patient who received proton therapy at HZB in 2019 was 8 years old, the oldest patient 96 years old. The average age was 61 years.
Since 1998, more than 3,700 patients have been treated with protons from the HZB accelerator. "The success of proton therapy is based on the collaboration between ophthalmologists, medical physicists and accelerator experts. As a result, the therapy has been continuously improved for the benefit of patients over the past few years", explains Prof. Dr. Andrea Denker, head of proton therapy at HZB.
- Strategisches Positionspapier zur Stärkung der SolarindustrieFrankfurt, 06. März 2025 – Die führenden deutschen Solarforschungseinrichtungen, die Fachabteilung „Photovoltaik Produktionsmittel“ des Industrieverbands VDMA und das Produktionsplanungs-Unternehmen RCT Solutions, haben ein gemeinsames Positionspapier zur Stärkung der deutschen und europäischen Solarindustrie veröffentlicht. Dieses wird nun an die Parteien übermittelt, die nach der Bundestagswahl im Bundestag vertreten sind. Ziel ist es, die vorgeschlagenen Maßnahmen in die Koalitionsverhandlungen einzubringen und damit die Grundlage für eine widerstandsfähige und wettbewerbsfähige Solarindustrie in Deutschland zu schaffen.
- Perovskite solar cells: thermal stress is the key to their long term stabilityPerovskite solar cells are highly efficient and low cost in production. However, they still lack stability over the decades under real weather conditions. An international research collaboration led by Prof. Antonio Abate has now published a perspective on this topic in the journal Nature Reviews Materials. They explored the effects of multiple thermal cycles on microstructures and interactions between different layers of perovskite solar cells. They conclude that thermal stress is the decisive factor in the degradation of metal-halide perovskites. Based on this, they derive the most promising strategies to increase the long-term stability of perovskite solar cells.
- BESSY II: Building block of the catalyst for oxygen formation in photosynthesis reproducedIn a small manganese oxide cluster, teams from HZB and HU Berlin have discovered a particularly exciting compound: two high spin manganese centres in two very different oxidation states and. This complex is the simplest model of a catalyst that occurs as a slightly larger cluster in natural photosynthesis, where it enables the formation of molecular oxygen. The discovery is considered an important step towards a complete understanding of photosynthesis.